These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36802711)
1. Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal-Drug Synergism in Metallodrug Design. Sumithaa C; Ganeshpandian M Mol Pharm; 2023 Mar; 20(3):1453-1479. PubMed ID: 36802711 [TBL] [Abstract][Full Text] [Related]
2. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
3. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity. Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247 [TBL] [Abstract][Full Text] [Related]
4. Development of Arene Ruthenium Antitumor Complexes. Su W; Tang Z; Li P Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008 [TBL] [Abstract][Full Text] [Related]
5. Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents. Biancalana L; Pampaloni G; Marchetti F Chimia (Aarau); 2017 Sep; 71(9):573-579. PubMed ID: 30188287 [TBL] [Abstract][Full Text] [Related]
7. New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent. Guerriero A; Oberhauser W; Riedel T; Peruzzini M; Dyson PJ; Gonsalvi L Inorg Chem; 2017 May; 56(10):5514-5518. PubMed ID: 28443659 [TBL] [Abstract][Full Text] [Related]
8. Antitumor Effect of Organometallic Half-Sandwich Ru(II)-Arene Complexes Bearing a Glutathione Han T; Wu Y; Han W; Yan K; Zhao J; Sun Y Inorg Chem; 2021 Sep; 60(17):13051-13061. PubMed ID: 34369147 [